Evidence map›Paper›PMID 32566566›Full record

ArticleAnnals of translational medicine2020

Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis.

Qi Zhou, Yelei Gao, Xingmei Wang, Rui Liu, Peipei Du, Xiaoqing Wang, Xianzhuo Zhang, Shuya Lu, Zijun Wang, Qianling Shi and 11 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 4 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 4 syntheses or guidelines pooled it, 226 citations in OpenAlex.

  1. Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Qi ZhouThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Yelei GaoDepartment of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Xingmei WangDepartment of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Rui LiuDepartment of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Peipei DuSchool of Public Health, Chengdu Medical College, Chengdu 610500, China.
Xiaoqing WangDepartment of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Xianzhuo ZhangThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Shuya LuEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Zijun WangEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Qianling ShiThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Weiguo LiDepartment of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Yanfang MaEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Xufei LuoSchool of Public Health, Lanzhou University, Lanzhou 730000, China.
Toshio FukuokaEmergency and Critical Care Center, the Department of General Medicine, Department of Research and Medical Education at Kurashiki Central Hospital, Kurashiki, Japan.
Hyeong Sik AhnDepartment of Preventive Medicine, Korea University College of Medicine, Seoul, Korea.
Myeong Soo LeeKorea Institute of Oriental Medicine, Daejeon, Korea.
Enmei LiuDepartment of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Yaolong ChenEvidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Zhengxiu LuoDepartment of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Kehu YangThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
COVID-19 Evidence and Recommendations Working Group
Chengdu Medical College · CNLanzhou University · CNChina International Science and Technology Cooperation · CNUniversity of Electronic Science and Technology of China · CNKorea University · KRKurashiki Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19, a disease caused by SARS-CoV-2 coronavirus, has now spread to most countries and regions of the world. As patients potentially infected by SARS-CoV-2 need to visit hospitals, the incidence of nosocomial infection can be expected to be high. Therefore, a comprehensive and objective understanding of nosocomial infection is needed to guide the prevention and control of the epidemic.

methodsWe searched major international and Chinese databases: Medicine, Web of Science, Embase, Cochrane, CBM (China Biology Medicine disc), CNKI (China National Knowledge Infrastructure) and Wanfang database for case series or case reports on nosocomial infections of COVID-19, SARS (severe acute respiratory syndromes) and MERS (Middle East respiratory syndrome) from their inception to March 31st, 2020. We conducted a meta-analysis of the proportion of nosocomial infection patients in the diagnosed patients, occupational distribution of nosocomial infection medical staff.

resultsWe included 40 studies. Among the confirmed patients, the proportions of nosocomial infections with early outbreaks of COVID-19, SARS, and MERS were 44.0%, 36.0%, and 56.0%, respectively. Of the confirmed patients, the medical staff and other hospital-acquired infections accounted for 33.0% and 2.0% of COVID-19 cases, 37.0% and 24.0% of SARS cases, and 19.0% and 36.0% of MERS cases, respectively. Nurses and doctors were the most affected among the infected medical staff. The mean numbers of secondary cases caused by one index patient were 29.3 and 6.3 for SARS and MERS, respectively.

conclusionsThe proportion of nosocomial infection in patients with COVID-19 was 44% in the early outbreak. Patients attending hospitals should take personal protection. Medical staff should be awareness of the disease to protect themselves and the patients.

Indexed as

COVID-19meta-analysisnosocomial infectionrapid review

Identifiers

PMID32566566
PMCPMC7290630
OpenAlexW3027465300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.